Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials

OBJECTIVES: To investigate the safety of ofatumumab retreatment in rheumatoid arthritis. METHODS: Patients with active rheumatoid arthritis participating in two phase III trials (OFA110635 and OFA110634) and a phase II extension trial (OFA111752) received individualised open-label ofatumumab retreat...

Descripción completa

Detalles Bibliográficos
Autores principales: Quattrocchi, Emilia, Østergaard, Mikkel, Taylor, Peter C., van Vollenhoven, Ronald F., Chu, Myron, Mallett, Stephen, Perry, Hayley, Kurrasch, Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919033/
https://www.ncbi.nlm.nih.gov/pubmed/27336685
http://dx.doi.org/10.1371/journal.pone.0157961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919033/
https://www.ncbi.nlm.nih.gov/pubmed/27336685
http://dx.doi.org/10.1371/journal.pone.0157961

Ejemplares similares